ADHD drug shortage tied to supply chain failures as Yale study links U.S. stimulant import declines to production cutbacks ...

Adult ADHD treatment surges as stimulant prescriptions more than double since the COVID-19 pandemic began, as a new study ...

Some adult professionals living with attention-deficit hyperactivity disorder (ADHD) manage their work tasks without much disruption. But others may face challenges like losing focus, struggling to ...

The use of prescription medications for Attention-Deficit Hyperactivity Disorder (ADHD) has tripled in the last decade - with women seeing the most "dramatic" increase, according to a major new study.

Add Yahoo as a preferred source to see more of our stories on Google. Robert F. Kennedy Jr. speaks after being sworn in as secretary of Health and Human Services in the Oval Office at the White House ...

Pediatricians are too quick to prescribe medication for young children with attention-deficit/hyperactivity disorder, a new analysis shows. The American Academy of ...

Collegium Pharmaceutical (COLL) has agreed to acquire Azstarys, a prescription medicine for attention deficit hyperactivity disorder (ADHD), in a deal worth up to $785M with privately held biopharma ...

In a bid to expand its reach in the attention-deficit/hyperactivity disorder (ADHD) market, Collegium Pharmaceutical has struck a deal to ...

WASHINGTON — Several lots of a prescription ADHD medication have been recalled due to some failed lab tests, according to FDA Enforcement Reports. The nationwide recall covers several batches of the ...

Because stimulants are not a cure for ADHD, but can be the key that opens the doors to effective behavioral and educational therapies, the reasons for treatment failures need to be found and fixed.

Attention-deficit hyperactivity disorder (ADHD) is a condition that develops during childhood and affects 6%–10% of kids and ...

Cerebral’s acquisition of Inflow equips the company with digital therapeutic tools designed to help patients manage their ...